InvestorsHub Logo

bluelucky

11/10/17 1:09 PM

#31193 RE: wimuskyfisherman #31192

Same with focalin. Both ir and xr

Thank you Fred very much. Really appreciate you sharing the info and your insights about this company

AngeloFoca

11/10/17 2:59 PM

#31200 RE: wimuskyfisherman #31192

Fred- Those prescription numbers you posted also include the standard Seroquel prescription as well as the XR

Ohhh... those #s had really depressed me... previously when fred posted comparison #s it showed MNK far outselling the other manufacturers... whereas these #s placed it at the bottom.

There is hope!!!


tilator

11/10/17 3:29 PM

#31202 RE: wimuskyfisherman #31192

Fred- Those prescription numbers you posted also include the standard Seroquel prescription as well as the XR. The standard prescriptions still far exceed the XR ones.



I suppose it has only XR:

"According to Symphony Health Solutions, sales of Seroquel XR® were approximately US$1.1 billion for the 12 months ending January 2017 (TRx MBS Dollars)."

http://www.intellipharmaceutics.com/product-detail.cfm?productID=118884

300k weekly prescriptions would make some US$1.5 billion sales if one prescription made US$100 sales.

I think there is really enough room for MNK sales, but do they take it seriously?